skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8851

Effect of once-daily FDC treatment era on initiation of cART

Original Research

(2717) Views  (455) Full article downloads

Authors: David M Mosen, Michael Horberg, Douglas Roblin, et al

Published Date February 2010 Volume 2010:2 Pages 19 - 26
DOI: http://dx.doi.org/10.2147/HIV.S8803

David M Mosen1, Michael Horberg2, Douglas Roblin3, Christina M Gullion1, Richard Meenan1, Wendy Leyden2, Weiming Hu1

1Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA; 2Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA; 3Center for Health Research, Kaiser Permanente Georgia, Atlanta, GA, USA

Objectives: Combination antiretroviral therapy (cART) is associated with increased survival among HIV-infected persons. Yet, no research to date has examined whether introduction of once-daily fixed-dosed combinations (FDC) affects the likelihood of cART initiation. We aimed to determine whether implementation of once-daily FDC regimens was associated with changes to cART initiation. We also identified clinical, treatment regimen, and provider characteristics possibly associated with cART initiation.

Study design: Retrospective observational analysis.

Methods: We queried electronic medical records between July 1999–June 2006 to identify incident cases of detectable HIV infection in antiretroviral-naïve adults. Cox regression with time-dependent covariates was used to examine the effects of once-daily FDC era, clinical, provider, and treatment regimen characteristics on cART initiation.

Results: Once-daily FDC availability did not change the likelihood of cART initiation, but other characteristics were associated with an increased likelihood: AIDS diagnosis, above-median daily pill consumption, and 16+ yrs of physician HIV experience. Decreased likelihood of cART initiation was associated with CD4 201–350 cells/µL, HIV RNA < 100,000 copies/mL, and with CD4 > 350 cells/µL (any HIV RNA level), compared to CD4 ≤ 200 cells/µL.

Conclusion: Availability of once-daily FDC-based regimens did not affect likelihood of cART initiation. Patient clinical characteristics appear to be more important predictors of cART initiation.

Keywords: ARV treatment, once-daily FDC therapies, ARV-naïve








Readers of this article also read:

Mitigating micro- and macro-vascular complications of diabetes beginning in adolescence
Ethanol suppression of peripheral blood mononuclear cell trafficking across brain endothelial cells in immunodeficiency virus infection
Novel mechanisms of central nervous system damage in HIV infection
Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study
Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells
Antiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives?
Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level
Characteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy
Seroprevalence of Toxoplasma gondii IgG antibody in HIV-infected patients at the Lagos University Teaching Hospital
The use of preexposure treatments for HIV prophylaxis